Analytik Jena AG /  / Ad hoc: Analytik Jena Announces Preliminary 
Figures for the 2008/2009
Financial Year
  
 processed and transmitted by Hugin. The issuer is solely responsible 
for the content of this announcement.     
   
----------------------------------------------------------------------
--------------




-          Sales rose to over EUR 71.0 m in the instrument business
-          Operating profit (EBIT) increased by 34.0 % to EUR 6.3 m
-          Earnings per share negatively impacted by increased income
tax rate
Jena, November 10, 2009 - Analytik Jena AG (Frankfurt DE0005213508,
Prime Standard: AJA) was still in line to achieve its main target in
the 2008/2009 financial year and continued to enjoy strong growth
despite the difficult overall economic climate. This was the
announcement made by the Company today at the German Equity
Conference held in Frankfurt am Main.
Over the past 2008/2009 financial year, the analytical, bioanalytical
and optical systems and applications manufacturer achieved sales of
EUR 71.2 m (previous year: EUR 53.1 m) in its instrument business.
The Company therefore posted sales growth of 34.1 % in its core
business, including the acquired subsidiaries CyBio AG and Biometra
GmbH. Organic growth alone stood at 10.3 %. In the segments
analytical solutions and bio solutions, Analytik Jena gained
significant ground, whilst sales in optical solutions were down
year-on-year.
Operating profit (EBIT) increased by 34.0 % to EUR 6.3 m (previous
year: EUR 4.7 m), which corresponds to an EBIT margin of 8.9 %.
Earnings before taxes (EBT) rose from EUR 2.9 m in the previous year
to expectedly more than EUR 4.0 m in this period.
Also the operating cash flow with nearly EUR 6.0 m compared with the
negative value of EUR -1.7 m in the previous year was developing
positively.
For earnings per share the Company cannot report any resilient
figures so far. This is attributable to tax burden by subsidiaries
abroad that need to be audited yet. An increased income tax compared
with the previous year is expected, so earnings per share will
probably be close to the previous year's result.
Considering the consolidating global economy and the positive
industry forecasts, Analytik Jena expects to continue its positive
development and its overall growth.
The figures given in the announcement are preliminary figures. The
final results for the 2008/2009 financial year (as of September 30)
will be announced by the Group on December 17, 2009.
Contact:
Dana Schmidt
Analytik Jena AG
Konrad-Zuse-Strasse 1
07745 Jena
Tel: +49 3641 779281
Mail: ir@analytik-jena.de


 
--- End of Message  ---

Analytik Jena AG
Konrad-Zuse-Straße 1 Jena Germany

WKN: 521350 ; 
ISIN: DE0005213508 ; Index: Prime All Share;
Listed: Prime Standard in Frankfurter Wertpapierbörse, Freiverkehr in 
Bayerische Börse München, 
Freiverkehr in Börse Berlin, Freiverkehr in Börse Düsseldorf, 
Freiverkehr in Börse Stuttgart, Freiverkehr in Hanseatische 
Wertpapierbörse zu Hamburg, 
Freiverkehr in Niedersächsische Börse zu Hannover, Regulierter Markt 
in Frankfurter Wertpapierbörse;